Sapienza University of Rome

Italy
6 Scholarships 45 Programs 3 Degree levels

Innovation in Immuno-Mediated and Hematological Disorders

Offered at Sapienza University of Rome, Italy
Duration3 years

Overview

The PhD in Innovation in Immuno-Mediated and Hematological Disorders at Sapienza University of Rome focuses on translating cutting-edge immunology and hematology research into clinically relevant advances. The programme is delivered through two research-focused curricula and supports international collaboration across Europe and North America.

About this programme

Overview

The PhD program in Innovation in Immuno-Mediated and Hematological Disorders at Sapienza University of Rome is designed to bridge the gap between innovative research in immunology and hematology and its clinical applications. This program emphasizes research excellence and international collaboration, fostering a comprehensive understanding of immuno-mediated disorders and hematological conditions.

What You'll Study

The program consists of two specialized curricula that focus on cutting-edge research themes:

Curriculum 1: Innovation in Immunology and Immunopathology

  • Advanced school of immunology
  • Flow cytometry training for high-parameter immune phenotyping
  • Cellular microscopy and image analysis techniques
  • Bioinformatics applications in immunology, from genomes to drug discovery
  • Microscopy techniques for life sciences research

Curriculum 2: Innovation in Hematology

  • Drug discovery and delivery relevant to translational hematology research
  • Single-cell transcriptomics, including theory and bioinformatics pipeline
  • Bioinformatics for biomedical research, focusing on genomics and drug development
  • Cellular microscopy and image analysis techniques
  • Microscopy techniques for life sciences research

Research Component

  • Candidates will develop an individual research project under the guidance of academic supervisors.
  • Progress is assessed through various milestones, including research reports and oral evaluations.

Entry Requirements

Applicants must possess a Master’s degree or an equivalent qualification recognized for admission into PhD programs. Proficiency in English is also required, demonstrated through standardized tests such as TOEFL, PTE Academic, or IELTS.

Career Prospects

Graduates of this PhD program will be well-equipped for careers in academia, research institutions, and the pharmaceutical industry. They will possess the skills necessary to contribute to advancements in immunology and hematology, making significant impacts on healthcare and clinical practices.